All Stories

  1. MicroRNAs as regulators of endothelial cell functions in cardiometabolic diseases

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, December 2016, Elsevier

    Elisa Araldi

  2. ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression

    Article • Nature Communications, July 2016, Nature

    Elisa Araldi

  3. miR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice

    Article • Atherosclerosis, December 2015, Elsevier

    Elisa Araldi

  4. Fibrosis and Hypoxia-Inducible Factor-1α–Dependent Tumors of the Soft Tissue on Loss of Von Hippel-Lindau in Mesenchymal Progenitors

    Article • American Journal Of Pathology, November 2015, Elsevier

    Elisa Araldi

  5. VEGF-Induced Expression of miR-17–92 Cluster in Endothelial Cells Is Mediated by ERK/ELK1 Activation and Regulates AngiogenesisNovelty and Significance

    Article • Circulation Research, October 2015, Wolters Kluwer Health

    Elisa Araldi

  6. MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels

    Article • Nature Reports Stem Cells, October 2015, Nature

    Elisa Araldi

  7. Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease

    Article • Current Vascular Pharmacology, July 2015, Bentham Science Publishers

    Elisa Araldi

  8. Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis

    Article • The FASEB Journal, November 2014, Federation of American Societies For Experimental Biology (FASEB)

    Elisa Araldi

  9. Loss of VHL in mesenchymal progenitors of the limb bud alters multiple steps of endochondral bone development

    Article • Developmental Biology, September 2014, Elsevier

    Elisa Araldi

  10. Improved repair of dermal wounds in mice lacking microRNA‐155

    Article • Journal of Cellular and Molecular Medicine, March 2014, Wiley

    Elisa Araldi

  11. MicroRNAs as pharmacological targets in endothelial cell function and dysfunction

    Article • Pharmacological Research, September 2013, Elsevier

    Elisa Araldi

  12. MiR-155 Has a Protective Role in the Development of Non-Alcoholic Hepatosteatosis in Mice

    Article • PLoS ONE, August 2013, PLOS

    Elisa Araldi

  13. Notch pathway activation targets AML-initiating cell homeostasis and differentiation

    Article • The Journal of Experimental Medicine, January 2013, Rockefeller University Press

    Elisa Araldi

  14. The HIF Signaling Pathway in Osteoblasts Directly Modulates Erythropoiesis through the Production of EPO

    Article • Cell, March 2012, Elsevier

    Elisa Araldi

  15. VEGF-independent cell-autonomous functions of HIF-1α regulating oxygen consumption in fetal cartilage are critical for chondrocyte survival

    Article • Journal of Bone and Mineral Research, February 2012, Wiley

    Elisa Araldi

  16. International Society for Extracellular Vesicles: first annual meeting, April 17–21, 2012: ISEV-2012

    Article • Journal of Extracellular Vesicles, January 2012, Taylor & Francis

    Elisa Araldi

  17. A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia

    Article • Nature, May 2011, Nature

    Elisa Araldi

  18. Lack of HIF-2α in limb bud mesenchyme causes a modest and transient delay of endochondral bone development

    Article • Nature Reports Stem Cells, January 2011, Nature

    Elisa Araldi

  19. Hypoxia, HIFs and bone development

    Article • Bone, August 2010, Elsevier

    Elisa Araldi

  20. MicroRNA-140 and the silencing of osteoarthritis

    Article • Genes & Development, June 2010, Cold Spring Harbor Laboratory Press

    Elisa Araldi